About iRhythm Technologies
What iRhythm Technologies is building
Technologies used at iRhythm Technologies
HTML5Company culture
Passion
We are passionate because we believe in what we are doing and where we are going. Our inspired determination drives our commitment to what we do and how we do it.
Boundaryless
We are open to accepting and sharing ideas, knowledge, advice and challenges. We evaluate new ideas and solutions with sincerity and honesty.
Funding rounds
Total Funding
Last funding round type
Company type
iRhythm Technologies news and updates
iRhythm Technologies received financing of $107M in IPO on Jan 1st 16'.
During King’s tenure, iRhythm went public in 2016, raised $107 million in an IPO, partnered with Verily Life Sciences, and advanced the wearable ECG device, Zio Patch.
Dec 12, 2022 | mddionline.comiRhythm Technologies launches Know Your Rhythm
This is precisely why iRhythm Technologies has launched Know Your Rhythm ®, its risk-sharing program where iRhythm Technologies partner with healthcare systems to evaluate for undiagnosed AFib and other arrhythmias and link this to evidence-based initiation of treatment.”
Nov 16, 2022 | irhythmtech.comiRhythm Technologies hires Brice Bobzien
iRhythm Technologies Inc. has appointed two seasoned executives to its leadership team: Brice Bobzien as chief financial officer (CFO) and Reyna Fernandez as executive vice president, chief Human Resources officer.
Aug 30, 2022 | mpo-mag.comLisle Medical partners with iRhythm Technologies
[Update Sep 2022 - Lisle Medical is now proud to partner with iRhythm Technologies in offering the Zio XT service.]
Apr 7, 2022 | lislemedical.comKevin King will retire from iRhythm Technologies as Board of Directors on Apr 1st 22'.
iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire from iRhythm’s Board of Directors effective April 1, 2022.
Jan 1, 2022 | globenewswire.comiRhythm Technologies partners with Silicon Valley Ban
iRhythm Technologies, Inc. ( IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced it has amended its existing debt facility with Silicon Valley Bank (the “Amended Credit Facility”).
Jan 1, 2022 | gurufocus.comiRhythm Technologies hired Mintu Turakhia as Chief Medical Officer and Chief Scientific Officer on Apr 28th 22'.
iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that Mintu Turakhia, M.D. M.A.S., will join iRhythm in the new role of Chief Medical Officer and Chief Scientific Officer.
Jan 1, 2022 | globenewswire.comiRhythm Technologies hired Judy Lenane as Chief Clinical Officer on Jan 1st 08'.
iRhythm also recently announced the hiring of Dr. Mintu Turakhia for the new role of chief medical officer and chief scientific officer, as well as the planned retirement of Chief Clinical Officer Judy Lenane.
Jan 1, 2022 | medicaldesignandoutsourcing.comiRhythm Technologies hires Chad Patterson as Chief Commercial Officer
The company also announced that Chad Patterson will join iRhythm’s executive leadership team as its new Chief Commercial Officer, managing the company’s commercial strategy, operations and execution.
Jan 1, 2022 | globenewswire.comiRhythm Technologies launches FDA clearance of ZEUS System for the Zio Watch
iRhythm Technologies, a digital healthcare solutions company focused on cardiac care advancements, announced FDA clearance of its ZEUS (Zio ECG Utilization Software) System for the Zio Watch.
Jan 1, 2022 | mddionline.comHere's Why iRhythm Technologies Stock Is Making Big Gains Today
A new CEO with an impressive record is giving investors hope for a rapid turnaround for the heart monitor maker.
Sep 13, 2021 | The Motley FooliRhythm wins FDA clearances for next-gen Zio monitor, AI capabilities
iRhythm Technologies (NSDQ:IRTC) announced that it received FDA 510(k) clearances for updates to its heart rhythm monitoring tech.
May 25, 2021 | Mass DeviceiRhythm’s revenue jumps 33% in Q4
iRhythm Technologies (NASDAQ: IRTC) reported mixed Q4 results but predicted strong sales growth in 2021.
Feb 26, 2021 | Mass DeviceiRhythm Technologies hired C. Noel Bairey Merz as Board of Directors on Apr 10th 18'.
iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today the appointment of C. Noel Bairey Merz, M.D. to its Board of Directors.
Apr 10, 2018 | irhythmtech.comiRhythm Technologies hired Karim Karti as Chief Operating Officer on Jul 23rd 18'.
iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today the appointment of Karim Karti to Chief Operating Officer effective July 23, 2018.
Jan 1, 2018 | irhythmtech.com